The impact of corporate governance on the cancer waiting time target of the English National Health Service hospitals
The impact of corporate governance on the cancer waiting time target of the English National Health Service hospitals
Purpose: this paper aims to examine the impact of a board-level governance bundle (i.e. size, independence, expertise, meetings, gender diversity and multiple directorships) on the non-financial performance of National Health Service (NHS) hospitals – and, separately, by hospital type (i.e. trusts hospitals and foundation trusts hospitals).
Design/methodology/approach: a logit regression for panel data is used for a sample of 128 NHS trusts and foundation trusts across England from 2014 to 2018. The data was hand-collected from NHS hospitals’ annual reports and Care Quality Commission reports. The cancer waiting time target (i.e. 62-day cancer referral and treatment target) is used to measure non-financial performance.
Findings: the main findings for NHS hospitals indicate that multiple directorships positively and significantly affect non-financial performance. However, board expertise and gender diversity have a negative and significant influence. When the sample is partitioned, the results remain the same for the NHS foundation trusts hospitals. For NHS trust hospitals, except for multiple directorships having a positive and significant effect, all remaining governance attributes have an insignificant impact.
Practical implications: the findings have implications for policymakers and practitioners as they move to implement measures to improve hospital performance against the cancer waiting time targets in the English NHS.
Originality/value: to the best of the authors’ knowledge, this is the first study to examine the impact of corporate governance on cancer waiting time targets in public hospitals. Overall, this paper contributes to the corporate governance literature, especially in the context of public hospitals, and has significant practical and theoretical implications.
Corporate governance, England, National Health Service, cancer waiting time, hospitals, non-financial performance
Alta'any, Mohammad
d8c7d897-7082-4e70-af13-2db6aa32eaf6
Tauringana, Ven
27634458-b041-4bc1-94da-3e031d777e4f
Achiro, Laura Obwona
85b85057-f916-448b-a69d-c72b5421fbf1
20 November 2024
Alta'any, Mohammad
d8c7d897-7082-4e70-af13-2db6aa32eaf6
Tauringana, Ven
27634458-b041-4bc1-94da-3e031d777e4f
Achiro, Laura Obwona
85b85057-f916-448b-a69d-c72b5421fbf1
Alta'any, Mohammad, Tauringana, Ven and Achiro, Laura Obwona
(2024)
The impact of corporate governance on the cancer waiting time target of the English National Health Service hospitals.
Corporate Governance.
(doi:10.1108/CG-02-2024-0107).
Abstract
Purpose: this paper aims to examine the impact of a board-level governance bundle (i.e. size, independence, expertise, meetings, gender diversity and multiple directorships) on the non-financial performance of National Health Service (NHS) hospitals – and, separately, by hospital type (i.e. trusts hospitals and foundation trusts hospitals).
Design/methodology/approach: a logit regression for panel data is used for a sample of 128 NHS trusts and foundation trusts across England from 2014 to 2018. The data was hand-collected from NHS hospitals’ annual reports and Care Quality Commission reports. The cancer waiting time target (i.e. 62-day cancer referral and treatment target) is used to measure non-financial performance.
Findings: the main findings for NHS hospitals indicate that multiple directorships positively and significantly affect non-financial performance. However, board expertise and gender diversity have a negative and significant influence. When the sample is partitioned, the results remain the same for the NHS foundation trusts hospitals. For NHS trust hospitals, except for multiple directorships having a positive and significant effect, all remaining governance attributes have an insignificant impact.
Practical implications: the findings have implications for policymakers and practitioners as they move to implement measures to improve hospital performance against the cancer waiting time targets in the English NHS.
Originality/value: to the best of the authors’ knowledge, this is the first study to examine the impact of corporate governance on cancer waiting time targets in public hospitals. Overall, this paper contributes to the corporate governance literature, especially in the context of public hospitals, and has significant practical and theoretical implications.
Other
Corporate governance and cancer waiting times
- Accepted Manuscript
More information
Accepted/In Press date: 4 November 2024
e-pub ahead of print date: 20 November 2024
Published date: 20 November 2024
Keywords:
Corporate governance, England, National Health Service, cancer waiting time, hospitals, non-financial performance
Identifiers
Local EPrints ID: 496076
URI: http://eprints.soton.ac.uk/id/eprint/496076
ISSN: 1472-0701
PURE UUID: d6a136a3-9890-4a74-886c-d489abc8436e
Catalogue record
Date deposited: 03 Dec 2024 17:31
Last modified: 07 Dec 2024 02:43
Export record
Altmetrics
Contributors
Author:
Mohammad Alta'any
Author:
Laura Obwona Achiro
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics